Find a Trial

Trial Summary


Protocol No.PHO-COG-ACNS1931
StatusOPEN TO ACCRUAL
Principal InvestigatorBatra, Sandeep
ScopeNational
PhasePhase III
Age GroupAdults and Children
TitleA Phase 3 Study of Selumetinib (NSC# 748727, IND# 77782) or Selumetinib in Combination with Vinblastine for non-NF1, non-TSC Patients with Recurrent or Progressive Low-Grade Gliomas (LGGs) Lacking BRAFV600E or IDH1 Mutations
Applicable Disease SitesBrain and Nervous System
Participating InstitutionsIU Health North Hospital
    Indiana University (IU)
      Treatment TypeTreatment
      ContactKevin Bell, Phone:
      Pager:
      Email: kevbell@iu.edu
      ContactJennifer Pencek, RN, BSNPhone: +1 317-944-2832
      Pager:
      Email: jpencek@iupui.edu